Hyderabad: Of the two vaccines approved for emergency use in India — Covishield and Covaxin — those receiving the latter as part of the anti-Covid-19 vaccination drive, will be under a close watch, definitely for at least one week from the day they receive their first dose.
“We will check their status every day for a week. Anyone receiving Covaxin, as per government of India guidelines, will also have to sign a consent form saying they are taking it voluntarily. While the recipients can self-report, we will also have daily checks. We will follow all protocols, whether Covaxin or Covishield,” Director of Health Services Dr G. Srinivasa Rao said.
When a reporter asked a question on the safety of Covaxin, the senior official said it was time to stop questioning Covaxin. Instead of questioning it, “We should be proud that it is developed in Hyderabad. It is a product of Telangana gadda (land). It is a totally indigenous vaccine. We should take pride in that,” the…